[Federal Register Volume 75, Number 54 (Monday, March 22, 2010)]
[Notices]
[Page 13560]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-6178]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): RFA DD 10-002 Public Health Research on Spina
Bifida, RFA DD 10-003 Public Health Research on Children and Adults
Living With Spina Bifida, RFA DD 10-004 Developing a Prospective
Assessment of the Development, Health, and Condition Progression in
Young Children With Spina Bifida,and RFA DP 10-006 Epidemiologic Study
of Inflammatory Bowel Disease, Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 9 a.m.-4 p.m., April 15, 2010 (Closed)
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of ``RFA DD 10-002 Public Health
Research on Spina Bifida, RFA DD 10-003 Public Health Research on
Children and Adults Living with Spina Bifida, RFA DD 10-004
Developing a Prospective Assessment of the Development, Health, and
Condition Progression in Young Children with Spina Bifida, and RFA
DP 10-006 Epidemiologic Study of Inflammatory Bowel Disease.''
Contact Person for More Information: Donald Blackman, Ph.D.,
Scientific Review Officer, National Center for Chronic Disease
Prevention and Health Promotion, Office of the Director, Extramural
Research Program Office, 4770 Buford Highway, NE., Mailstop K-92,
Atlanta, GA 30341, Telephone: (770) 488-3023, Email: [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 12, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-6178 Filed 3-23-10; 8:45 am]
BILLING CODE 4163-18-P